Among the other genes that were consistently down-regulated by lapatinib in HER2-overexpressing cells, GCN5L2 is a still poorly characterized histone deacetylase whose expression was found to correlate with ERα in breast cancer [16]. The gene discussed is KAT2A; the disease is breast carcinoma.